English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18054/20253 (89%)
Visitors : 24214207      Online Users : 61
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34133

    標題: D-methionine improves cisplatin-induced anorexia and dyspepsia syndrome by attenuating intestinal tryptophan hydroxylase 1 activity and increasing plasma leptin concentration
    作者: Wong, Yi-Sin
    Lin, Meei-Yn
    Liu, Pei-Fen
    Ko, Jiunn-Liang
    Huang, Guan-Ting
    Tu, Dom-Gene
    Ou, Chu-Chyn
    貢獻者: Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Family Med
    Chia Nan Univ Pharm & Sci, Dept Food Sci & Technol
    Natl Chung Hsing Univ, Dept Food Sci & Biotechnol
    Chung Shan Med Univ Hosp, Dept Med Oncol & Chest Med
    Chung Shan Med Univ, Inst Med
    Chung Shan Med Univ Hosp, Dept Nutr
    Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Nucl Med
    Natl Chung Cheng Univ, Dept Biomed Sci
    Chung Shan Med Univ, Sch Nutr
    關鍵字: 5-HT3 receptor
    dyspepsia syndrome
    日期: 2020
    上傳時間: 2022-11-18 11:25:21 (UTC+8)
    出版者: Wiley
    摘要: Background Cisplatin is a widely used antineoplastic drug. However, cisplatin-induced dyspepsia syndromes, including delayed gastric emptying, gastric distension, early satiety, nausea, and vomiting, often force patients to take doses lower than those prescribed or even refuse treatment. D-methionine has an appetite-enhancing effect and alleviates weight loss during cisplatin treatment. Methods This work established a model of anorexia and dyspepsia symptoms with intraperitoneal injection of cisplatin (5 mg/kg) once a week for three cycles. Presupplementation with or without D-methionine (300 mg/kg) was performed. Orexigenic and anorexigenic hormones (ghrelin, leptin, and glucagon-like peptide-1), tryptophan hydroxylase 1 (TPH1), 5-hydroxytryptamine receptors (5-HT2C and 5-HT3), and hypothalamic feeding-related peptides were measured by immunohistochemistry staining, enzyme-linked immunosorbent assay, and real-time PCR assay. Key results Cisplatin administration caused marked decrease in appetite and body weight, promoted adipose and fat tissue atrophy, and delayed gastric emptying and gastric distension, and D-methionine preadministration prior to cisplatin administration significantly ameliorated these side effects. Besides, cisplatin induced an evident increase in serum ghrelin level, TPH1 activity, and 5-HT3 receptor expression in the intestine and decreased plasma leptin levels and gastric ghrelin mRNA gene expression levels. D-methionine supplementation recovered these changes. The expression of orexigenic neuropeptide Y/agouti-related peptide and anorexigenic cocaine- and amphetamine-regulated transcript proopiomelanocortin neurons were altered by D-methionine supplementation in cisplatin-induced anorexia rats. Conclusions and inferences D-methionine supplementation prevents cisplatin-induced anorexia and dyspepsia syndrome possibly by attenuating intestinal tryptophan hydroxylase 1 activity and increasing plasma leptin concentration. Therefore, D-methionine can be used as an adjuvant therapy for treating cisplatin-induced adverse effects.
    關聯: Neurogastroenterology and Motility, v.32, n.6, pp.13
    Appears in Collections:[ 食品科技系 ] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback